These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 8128091)
1. [The kinetics of IL-2 after pleural administration in the treatment of neoplastic pleurisy]. Astoul P; Bertault-Peres P; Durand A; Boutin C Rev Mal Respir; 1994; 11(1):29-35. PubMed ID: 8128091 [TBL] [Abstract][Full Text] [Related]
2. Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion. Astoul P; Viallat JR; Laurent JC; Brandely M; Boutin C Chest; 1993 Jan; 103(1):209-13. PubMed ID: 8417880 [TBL] [Abstract][Full Text] [Related]
3. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma. Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885 [TBL] [Abstract][Full Text] [Related]
4. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694 [TBL] [Abstract][Full Text] [Related]
5. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma. Lu C; Perez-Soler R; Piperdi B; Walsh GL; Swisher SG; Smythe WR; Shin HJ; Ro JY; Feng L; Truong M; Yalamanchili A; Lopez-Berestein G; Hong WK; Khokhar AR; Shin DM J Clin Oncol; 2005 May; 23(15):3495-501. PubMed ID: 15908659 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of mesothelioma with interferon gamma and interleukin 2]. Boutin C; Viallat JR; Astoul P Rev Pneumol Clin; 1990; 46(5):211-5. PubMed ID: 2127468 [TBL] [Abstract][Full Text] [Related]
7. [Thoracoscopy in pleural mesothelioma]. Zhang DH; Gu YT; Pan WS Zhonghua Jie He He Hu Xi Za Zhi; 1993 Jun; 16(3):150-3, 187. PubMed ID: 8242812 [TBL] [Abstract][Full Text] [Related]
8. Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma. Eton O; Rosenblum MG; Legha SS; Zhang W; Jo East M; Bedikian A; Papadopoulos N; Buzaid A; Benjamin RS Cancer; 2002 Jul; 95(1):127-34. PubMed ID: 12115326 [TBL] [Abstract][Full Text] [Related]
10. Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study. Goey SH; Eggermont AM; Punt CJ; Slingerland R; Gratama JW; Oosterom R; Oskam R; Bolhuis RL; Stoter G Br J Cancer; 1995 Nov; 72(5):1283-8. PubMed ID: 7577483 [TBL] [Abstract][Full Text] [Related]
11. [Clinical treatment with cisplatin (CDDP) in pleural cavity for carcinomatous pleurisy--study of intraarterial concentration]. Hara S; Tagawa Y; Tsuji H; Oka T; Morinaga M; Shingu H; Nagayasu T; Ikuta Y; Ayabe H Gan To Kagaku Ryoho; 1996 Sep; 23(11):1509-11. PubMed ID: 8854792 [TBL] [Abstract][Full Text] [Related]
12. Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients. Castagneto B; Zai S; Mutti L; Lazzaro A; Ridolfi R; Piccolini E; Ardizzoni A; Fumagalli L; Valsuani G; Botta M Lung Cancer; 2001; 31(2-3):303-10. PubMed ID: 11165411 [TBL] [Abstract][Full Text] [Related]
13. Intrapleural immunotherapy with escalating doses of interleukin-2 in metastatic pleural effusions. Viallat JR; Boutin C; Rey F; Astoul P; Farisse P; Brandely M Cancer; 1993 Jun; 71(12):4067-71. PubMed ID: 8508372 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intrapleural recombinant interleukin-2 in immunotherapy for malignant pleural effusion. Astoul P; Bertault-Peres P; Durand A; Catalin J; Vignal F; Boutin C Cancer; 1994 Jan; 73(2):308-13. PubMed ID: 8293393 [TBL] [Abstract][Full Text] [Related]
15. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. Yasumoto K; Mivazaki K; Nagashima A; Ishida T; Kuda T; Yano T; Sugimachi K; Nomoto K Cancer Res; 1987 Apr; 47(8):2184-7. PubMed ID: 3493843 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics and pleural reaction of doxycycline after intrapleural administration]. Homma T; Yoneda S; Komuro Y; Yoshida S; Min KY; Takayama S Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1129-34. PubMed ID: 6870294 [TBL] [Abstract][Full Text] [Related]
17. [Diagnostic and therapeutic thoracoscopy in 83 cases of chronic pleurisy]. Ladjimi S; Djemel A; Ben Youssef R; Ben Ayed F; Jaziri M; Belhassen S; Kammoun M; Zegaya M; Mourali N Rev Mal Respir; 1985; 2(6):355-9. PubMed ID: 3835612 [TBL] [Abstract][Full Text] [Related]
18. Pathology of the pleura: what the pulmonologists need to know. Cagle PT; Allen TC Respirology; 2011 Apr; 16(3):430-8. PubMed ID: 21362105 [TBL] [Abstract][Full Text] [Related]
19. Bolus high dose interleukin-2 for the treatment of malignant melanoma. Pappo I; Lotem M; Klein M; Orda R Isr Med Assoc J; 2001 Mar; 3(3):169-73. PubMed ID: 11303372 [TBL] [Abstract][Full Text] [Related]
20. [Pathology of the pleura]. Boutin C Rev Prat; 1990 Sep; 40(20):1821-2. PubMed ID: 2218344 [No Abstract] [Full Text] [Related] [Next] [New Search]